178 related articles for article (PubMed ID: 37730674)
1. Genetic reversal of the globin switch concurrently modulates both fetal and sickle hemoglobin and reduces red cell sickling.
De Souza DC; Hebert N; Esrick EB; Ciuculescu MF; Archer NM; Armant M; Audureau É; Brendel C; Di Caprio G; Galactéros F; Liu D; McCabe A; Morris E; Schonbrun E; Williams D; Wood DK; Williams DA; Bartolucci P; Higgins JM
Nat Commun; 2023 Sep; 14(1):5850. PubMed ID: 37730674
[TBL] [Abstract][Full Text] [Related]
2. Post-Transcriptional Genetic Silencing of
Esrick EB; Lehmann LE; Biffi A; Achebe M; Brendel C; Ciuculescu MF; Daley H; MacKinnon B; Morris E; Federico A; Abriss D; Boardman K; Khelladi R; Shaw K; Negre H; Negre O; Nikiforow S; Ritz J; Pai SY; London WB; Dansereau C; Heeney MM; Armant M; Manis JP; Williams DA
N Engl J Med; 2021 Jan; 384(3):205-215. PubMed ID: 33283990
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyurea differentially modulates activator and repressors of γ-globin gene in erythroblasts of responsive and non-responsive patients with sickle cell disease in correlation with Index of Hydroxyurea Responsiveness.
Zhu X; Hu T; Ho MH; Wang Y; Yu M; Patel N; Pi W; Choi JH; Xu H; Ganapathy V; Kutlar F; Kutlar A; Tuan D
Haematologica; 2017 Dec; 102(12):1995-2004. PubMed ID: 28971909
[TBL] [Abstract][Full Text] [Related]
4. Individual red blood cell fetal hemoglobin quantification allows to determine protective thresholds in sickle cell disease.
Hebert N; Rakotoson MG; Bodivit G; Audureau E; Bencheikh L; Kiger L; Oubaya N; Pakdaman S; Sakka M; Di Liberto G; Chadebech P; Vingert B; Pirenne F; Galactéros F; Cambot M; Bartolucci P
Am J Hematol; 2020 Nov; 95(11):1235-1245. PubMed ID: 32681733
[TBL] [Abstract][Full Text] [Related]
5. Reticulocyte parameters and hemoglobin F production in sickle cell disease patients undergoing hydroxyurea therapy.
Borba R; Lima CS; Grotto HZ
J Clin Lab Anal; 2003; 17(2):66-72. PubMed ID: 12640630
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyurea down-regulates BCL11A, KLF-1 and MYB through miRNA-mediated actions to induce γ-globin expression: implications for new therapeutic approaches of sickle cell disease.
Pule GD; Mowla S; Novitzky N; Wonkam A
Clin Transl Med; 2016 Mar; 5(1):15. PubMed ID: 27056246
[TBL] [Abstract][Full Text] [Related]
7. Concordant fetal hemoglobin response to hydroxyurea in siblings with sickle cell disease.
Steinberg MH; Voskaridou E; Kutlar A; Loukopoulos D; Koshy M; Ballas SK; Castro O; Barton F
Am J Hematol; 2003 Feb; 72(2):121-6. PubMed ID: 12555216
[TBL] [Abstract][Full Text] [Related]
8. Mechanism for fetal hemoglobin induction by hydroxyurea in sickle cell erythroid progenitors.
Baliga BS; Pace BS; Chen HH; Shah AK; Yang YM
Am J Hematol; 2000 Nov; 65(3):227-33. PubMed ID: 11074540
[TBL] [Abstract][Full Text] [Related]
9. Fetal hemoglobin in sickle cell anemia: a glass half full?
Steinberg MH; Chui DH; Dover GJ; Sebastiani P; Alsultan A
Blood; 2014 Jan; 123(4):481-5. PubMed ID: 24222332
[TBL] [Abstract][Full Text] [Related]
10. A systematic review of known mechanisms of hydroxyurea-induced fetal hemoglobin for treatment of sickle cell disease.
Pule GD; Mowla S; Novitzky N; Wiysonge CS; Wonkam A
Expert Rev Hematol; 2015 Oct; 8(5):669-79. PubMed ID: 26327494
[TBL] [Abstract][Full Text] [Related]
11. The role of BCL11A and HMIP-2 polymorphisms on endogenous and hydroxyurea induced levels of fetal hemoglobin in sickle cell anemia patients from southern Brazil.
Friedrisch JR; Sheehan V; Flanagan JM; Baldan A; Summarell CC; Bittar CM; Friedrisch BK; Wilke II; Ribeiro CB; Daudt LE; da Rocha Silla LM
Blood Cells Mol Dis; 2016 Nov; 62():32-37. PubMed ID: 27838552
[TBL] [Abstract][Full Text] [Related]
12. Metformin induces FOXO3-dependent fetal hemoglobin production in human primary erythroid cells.
Zhang Y; Paikari A; Sumazin P; Ginter Summarell CC; Crosby JR; Boerwinkle E; Weiss MJ; Sheehan VA
Blood; 2018 Jul; 132(3):321-333. PubMed ID: 29884740
[TBL] [Abstract][Full Text] [Related]
13. Variation in fetal hemoglobin parameters and predicted hemoglobin S polymerization in sickle cell children in the first two years of life: Parisian Prospective Study on Sickle Cell Disease.
Maier-Redelsperger M; Noguchi CT; de Montalembert M; Rodgers GP; Schechter AN; Gourbil A; Blanchard D; Jais JP; Ducrocq R; Peltier JY
Blood; 1994 Nov; 84(9):3182-8. PubMed ID: 7524767
[TBL] [Abstract][Full Text] [Related]
14. Dense red blood cell and oxygen desaturation in sickle-cell disease.
Di Liberto G; Kiger L; Marden MC; Boyer L; Poitrine FC; Conti M; Rakotoson MG; Habibi A; Khorgami S; Vingert B; Maitre B; Galacteros F; Pirenne F; Bartolucci P
Am J Hematol; 2016 Oct; 91(10):1008-13. PubMed ID: 27380930
[TBL] [Abstract][Full Text] [Related]
15. Sickling of nucleated erythroid precursors from patients with sickle cell anemia.
Hasegawa S; Rodgers GP; Dwyer N; Noguchi CT; Blanchette-Mackie EJ; Uyesaka N; Schechter AN; Fibach E
Exp Hematol; 1998 Apr; 26(4):314-9. PubMed ID: 9546314
[TBL] [Abstract][Full Text] [Related]
16. Sustained fetal hemoglobin induction in vivo is achieved by
Uchida N; Ferrara F; Drysdale CM; Yapundich M; Gamer J; Nassehi T; DiNicola J; Shibata Y; Wielgosz M; Kim YS; Bauler M; Throm RE; Haro-Mora JJ; Demirci S; Bonifacino AC; Krouse AE; Linde NS; Donahue RE; Ryu B; Tisdale JF
Sci Transl Med; 2021 Apr; 13(591):. PubMed ID: 33910976
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults.
Charache S
Semin Hematol; 1997 Jul; 34(3 Suppl 3):15-21. PubMed ID: 9317197
[TBL] [Abstract][Full Text] [Related]
18. Spectrum of fetal hemoglobin responses in sickle cell patients treated with hydroxyurea: the National Institutes of Health experience.
Rodgers GP
Semin Oncol; 1992 Jun; 19(3 Suppl 9):67-73. PubMed ID: 1379375
[TBL] [Abstract][Full Text] [Related]
19. Fetal hemoglobin regulating genetic variants identified in homozygous (HbSS) and heterozygous (HbSA) subjects from South Mexico.
Rizo-de la Torre LC; Borrayo-López FJ; Perea-Díaz FJ; Aquino E; Venegas M; Hernández-Carbajal C; Espinoza-Mata LL; Ibarra-Cortés B
J Trop Pediatr; 2022 Aug; 68(5):. PubMed ID: 36130307
[TBL] [Abstract][Full Text] [Related]
20. MetAP2 inhibition modifies hemoglobin S to delay polymerization and improves blood flow in sickle cell disease.
Demers M; Sturtevant S; Guertin KR; Gupta D; Desai K; Vieira BF; Li W; Hicks A; Ismail A; Gonçalves BP; Di Caprio G; Schonbrun E; Hansen S; Musayev FN; Safo MK; Wood DK; Higgins JM; Light DR
Blood Adv; 2021 Mar; 5(5):1388-1402. PubMed ID: 33661300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]